StockGlow

Innovent Biologics, Inc. (6IB.F)

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally.

9.42-0.03%Healthcare
Compare 6IB.F with
StockGlow Score
65
Leaning Bullish
BearishBullish
1 year ago-6.7%

The outlook

Innovent Biologics, Inc. currently reads as leaning bullish based on above its 50- & 200-day averages, 40% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range40% of the way from its 52-week low to high
Market cap
$16.40B
52-wk high
11.70
52-wk low
7.91
50-day avg
9.04
200-day avg
9.27
Trailing P/E
157.0

Similar stocks

SMZ1.FSino Biopharmaceutical Limited$0.55-0.47%8SJ.FShanghai Junshi Biosciences Co., Ltd.$2.00-0.99%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%4DN.FDenali Therapeutics Inc.$21.10+1.83%4DN.MUDenali Therapeutics Inc.$21.14+1.63%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy